top of page
The Professional Network for Healthcare Experts
China approves Bio-Thera's Ashuli as its first golimumab biosimilar
Bio-Thera has secured Chinese regulatory approval for Ashuli, the country's first golimumab biosimilar, expanding domestic biosimilar competition in rheumatoid arthritis and ankylosing spondylitis.
nuaxia
23 hours ago2 min read
Brazil approves Henlius and Organon's pertuzumab biosimilar for HER2-positive breast cancer
Brazil's health regulator has approved Henlius and Organon's pertuzumab biosimilar for certain HER2-positive breast cancer patients, marking the country's first authorisation of a biosimilar to this established oncology antibody.
nuaxia
23 hours ago2 min read
bottom of page